Alimera Sciences Reports First Quarter 2022 Results
Consolidated Net Revenue of $11.9 Million Up 6% vs. First Quarter of 2021U.S. Net Revenue Increased 23% vs. First Quarter...
Year: 2022
Aadi Bioscience Announces Collaborations with Next Generation Sequencing Leaders
Company enters into collaborations with leading next generation sequencing (NGS) companies to facilitate trial enrollment for PRECISION 1, the Company’s...
Synthetic Biologics to Host Conference Call and Webcast to Discuss First Quarter 2022 Operational Highlights and Financial Results
ROCKVILLE, Md., May 09, 2022 (GLOBE NEWSWIRE) -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company developing therapeutics...
Apexigen to Host Investor Day on Antibody Therapeutic Pipeline and Unique APXiMAB™ Platform
-Webinar to be held Monday, May 16th at 8:00 a.m. PT/ 11:00 a.m. ET-SAN CARLOS, Calif., May 09, 2022 (GLOBE...
Eledon Pharmaceuticals Announces First Patient Dosed in Phase 2a Trial Evaluating Tegoprubart in IgA Nephropathy
Initial data from open label Phase 2a study expected in late 2022IRVINE, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- Eledon...
PetMeds® Hires Pet-Industry Veteran into Pivotal Leadership Role
In her new role as VP of Product Management, Carolyn Carden will scale PetMeds’ product portfolio, including its rapidly growing...
BrainsWay Appoints Eric Hirt as Vice President of U.S. Sales
Veteran Medical Device Industry Sales and Marketing Executive Has Over 20 Years of ExperienceBURLINGTON, Mass. and JERUSALEM, May 09, 2022...
LianBio Completes Phase 1 Pharmacokinetic Study of Mavacamten in Healthy Chinese Volunteers
Mavacamten demonstrated a favorable safety, tolerability and pharmacokinetic profile in healthy Chinese volunteers Study was conducted in parallel with ongoing...
Ultragenyx Announces Upcoming Data Presentations at American Society of Gene & Cell Therapy (ASGCT) 2022 Annual Meeting
Oral presentations include longer term durability data from DTX301 and DTX401, and manufacturing data on the Pinnacle PCL™ (AAV vector...
Lucira Receives CE Mark for both COVID-19 & Flu and COVID-19 Molecular Tests
Lucira COVID-19 Test Packaging Lucira COVID-19 Test Packaging Lucira COVID-19 & Flu Test Packaging Lucira COVID-19 & Flu Test PackagingEMERYVILLE,...
Compass Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Company Progress
The FDA cleared the investigational new drug application for CTX-009 (DLL4 X VEGF-A bispecific) in January allowing the Company to...
MIMEDX Comments on Prescience Point’s False and Misleading Statements
Cautions Shareholders Not to Let Prescience Point Unravel MIMEDX’s Transformation Urges Shareholders to Protect their Investments by Voting “FOR” Dr....
Ventyx Biosciences Announces Appointment of William Sandborn, MD, as President and Chief Medical Officer
Dr. Sandborn brings a wealth of clinical experience and knowledge to Ventyx as we advance our clinical-stage pipeline of novel oral...
Arch Therapeutics’ Experts in Wound Care Interview Showcases AC5 Self-Assembling Peptide Technology During Live Session at SAWC Spring
World-renowned Wound Care Leaders, Terry Treadwell, MD, FACS and Brock Liden, DPM, Shared Insights on Success with AC5® Advanced Wound...
Vaxxinity Reports First Quarter 2022 Financial Results and Provides Corporate Updates
DALLAS, May 09, 2022 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new...
Adaptimmune Reports First Quarter Financial Results and Business Update
- Pooled data from Cohort 1 of the SPEARHEAD-1 trial and the Phase 1 trial of afami-cel in patients with...
Genenta Appoints Industry Veteran Tim Obara as Head of Business Development
Extensive experience in business development with AstraZeneca and GSKMILAN, Italy and NEW YORK, May 09, 2022 (GLOBE NEWSWIRE) -- Genenta...
Verrica Pharmaceuticals Reports First Quarter 2022 Financial Results
Upcoming PDUFA date of May 24, 2022 for VP-102 NDA for the treatment of molluscum First patient dosed in Phase...
VectivBio to Participate at the Bank of America 2022 Healthcare Conference
BASEL, Switzerland, May 09, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel...
Resverlogix Announces Type C Meeting with FDA for CORAL, a Phase 3 High-risk COVID-19 Outpatient Study
CALGARY, Alberta, May 09, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix", or "the Company") (TSX:RVX), in partnership with EVERSANA™, today...
